Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (231-240 of 337) with videos related to

Pageof 34
Sort By:
The Journal of Antimicrobial Chemotherapy|January 1, 2019
Protein binding of rifampicin is not saturated when using high-dose rifampicinCarlijn H C Litjens, Rob E Aarnoutse, Eleonora W J van Ewijk-Beneken Kolmer, et al.
Clinical Pharmacokinetics|January 9, 2021
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic AnalysisNikki de Rouw, Rene J Boosman, Alwin D R Huitema, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion modelStein Schalkwijk, Rick Greupink, Angela P Colbers, et al.
British Journal of Clinical Pharmacology|April 7, 2018
Large differences in neonatal drug use between NICUs are common practice: time for consensus?Robert B Flint, Floor van Beek, Peter Andriessen, et al.
Biomedical Chromatography : BMC|April 4, 2017
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasmaGuillemette E Benoist, Eric van der Meulen, Floor J E Lubberman, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
International interlaboratory quality control program for measurement of antiretroviral drugs in plasmaRob E Aarnoutse, Corrien P W G M Verweij-van Wissen, Eleonora W J van Ewijk-Beneken Kolmer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 19, 2014
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trialAmir I A Ahmed, Geke A H van den Elsen, Angela Colbers, et al.
British Journal of Clinical Pharmacology|January 29, 2021
The potential of individualized dosing of ravulizumab to improve patient-friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costsMendy Ter Avest, Saskia M C Langemeijer, Saskia E M Schols, et al.
AIDS (London, England)|September 16, 2022
Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara AfricaHylke Waalewijn, Kim Stol, Linda van der Knaap, et al.
Clinical Pharmacology and Therapeutics|April 17, 2020
Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen SusceptibilityEmilie M Gieling, Eveline Wallenburg, Tim Frenzel, et al.
Pageof 34

Showing results (231-240 of 337) with videos related to

Sort By:
Pageof 34
The Journal of Antimicrobial Chemotherapy|January 1, 2019
Protein binding of rifampicin is not saturated when using high-dose rifampicinCarlijn H C Litjens, Rob E Aarnoutse, Eleonora W J van Ewijk-Beneken Kolmer, et al.
Clinical Pharmacokinetics|January 9, 2021
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic AnalysisNikki de Rouw, Rene J Boosman, Alwin D R Huitema, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion modelStein Schalkwijk, Rick Greupink, Angela P Colbers, et al.
British Journal of Clinical Pharmacology|April 7, 2018
Large differences in neonatal drug use between NICUs are common practice: time for consensus?Robert B Flint, Floor van Beek, Peter Andriessen, et al.
Biomedical Chromatography : BMC|April 4, 2017
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasmaGuillemette E Benoist, Eric van der Meulen, Floor J E Lubberman, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
International interlaboratory quality control program for measurement of antiretroviral drugs in plasmaRob E Aarnoutse, Corrien P W G M Verweij-van Wissen, Eleonora W J van Ewijk-Beneken Kolmer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 19, 2014
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trialAmir I A Ahmed, Geke A H van den Elsen, Angela Colbers, et al.
British Journal of Clinical Pharmacology|January 29, 2021
The potential of individualized dosing of ravulizumab to improve patient-friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costsMendy Ter Avest, Saskia M C Langemeijer, Saskia E M Schols, et al.
AIDS (London, England)|September 16, 2022
Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara AfricaHylke Waalewijn, Kim Stol, Linda van der Knaap, et al.
Clinical Pharmacology and Therapeutics|April 17, 2020
Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen SusceptibilityEmilie M Gieling, Eveline Wallenburg, Tim Frenzel, et al.
Pageof 34